Literature DB >> 35750299

Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.

Paulo A De Oliveira1, Estefanía Moreno2, Nil Casajuana-Martin3, Verònica Casadó-Anguera2, Ning-Sheng Cai1, Gisela Andrea Camacho-Hernandez4, Hu Zhu5, Alessandro Bonifazi4, Matthew D Hall5, David Weinshenker6, Amy Hauck Newman4, Diomedes E Logothetis7, Vicent Casadó8, Leigh D Plant9, Leonardo Pardo10, Sergi Ferré11.   

Abstract

Recent studies have proposed that heteromers of µ-opioid receptors (MORs) and galanin Gal1 receptors (Gal1Rs) localized in the mesencephalon mediate the dopaminergic effects of opioids. The present study reports converging evidence, using a peptide-interfering approach combined with biophysical and biochemical techniques, including total internal reflection fluorescence microscopy, for a predominant homodimeric structure of MOR and Gal1R when expressed individually, and for their preference to form functional heterotetramers when co-expressed. Results show that a heteromerization-dependent change in the Gal1R homodimeric interface leads to a switch in G-protein coupling from inhibitory Gi to stimulatory Gs proteins. The MOR-Gal1R heterotetramer, which is thus bound to Gs via the Gal1R homodimer and Gi via the MOR homodimer, provides the framework for a canonical Gs-Gi antagonist interaction at the adenylyl cyclase level. These novel results shed light on the intense debate about the oligomeric quaternary structure of G protein-coupled receptors, their predilection for heteromer formation, and the resulting functional significance. Published by Elsevier Ltd.

Entities:  

Keywords:  DAMGO (PubChem CID: 5462471); Endomorphin-1 (PubChem CID: 5311080); Fentanyl (PubChem CID: 3345); G protein coupled receptor oligomerization; Galanin (PubChem CID: 16133823); Galanin receptors; M40 (PubChem CID: 16133821); M617 (PubChem CID: 16158157); Methadone (PubChem CID: 4095); Naloxone (PubChem CID: 5284596); Opioid receptors; Total internal reflection fluorescence microscopy

Mesh:

Substances:

Year:  2022        PMID: 35750299      PMCID: PMC9462584          DOI: 10.1016/j.phrs.2022.106322

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   10.334


  58 in total

1.  Subunit counting in membrane-bound proteins.

Authors:  Maximilian H Ulbrich; Ehud Y Isacoff
Journal:  Nat Methods       Date:  2007-03-18       Impact factor: 28.547

2.  Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus.

Authors:  G A Kinney; P J Emmerson; R J Miller
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

Review 3.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

Review 4.  Structure and function of adenosine receptor heteromers.

Authors:  Rafael Franco; Arnau Cordomí; Claudia Llinas Del Torrent; Alejandro Lillo; Joan Serrano-Marín; Gemma Navarro; Leonardo Pardo
Journal:  Cell Mol Life Sci       Date:  2021-02-12       Impact factor: 9.261

5.  Galanin receptor antagonists M40 and C7 block galanin-induced feeding.

Authors:  J N Crawley; J K Robinson; U Langel; T Bartfai
Journal:  Brain Res       Date:  1993-01-15       Impact factor: 3.252

6.  Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.

Authors:  Xiao-Ying Hua; Carol S Hayes; Anthony Hofer; Bethany Fitzsimmons; Kalle Kilk; Ulo Langel; Tamas Bartfai; Tony L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

7.  Single-molecule FRET imaging of GPCR dimers in living cells.

Authors:  Wesley B Asher; Peter Geggier; Michael D Holsey; Grant T Gilmore; Avik K Pati; Jozsef Meszaros; Daniel S Terry; Signe Mathiasen; Megan J Kaliszewski; Mitchell D McCauley; Alekhya Govindaraju; Zhou Zhou; Kaleeckal G Harikumar; Khuloud Jaqaman; Laurence J Miller; Adam W Smith; Scott C Blanchard; Jonathan A Javitch
Journal:  Nat Methods       Date:  2021-03-08       Impact factor: 28.547

8.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

9.  Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.

Authors:  Xavier Viñals; Estefanía Moreno; Laurence Lanfumey; Arnau Cordomí; Antoni Pastor; Rafael de La Torre; Paola Gasperini; Gemma Navarro; Lesley A Howell; Leonardo Pardo; Carmen Lluís; Enric I Canela; Peter J McCormick; Rafael Maldonado; Patricia Robledo
Journal:  PLoS Biol       Date:  2015-07-09       Impact factor: 8.029

10.  Molecular basis for allosteric agonism and G protein subtype selectivity of galanin receptors.

Authors:  Jia Duan; Dan-Dan Shen; Tingting Zhao; Shimeng Guo; Xinheng He; Wanchao Yin; Peiyu Xu; Yujie Ji; Li-Nan Chen; Jinyu Liu; Huibing Zhang; Qiufeng Liu; Yi Shi; Xi Cheng; Hualiang Jiang; H Eric Xu; Yan Zhang; Xin Xie; Yi Jiang
Journal:  Nat Commun       Date:  2022-03-15       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.